UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC cut its stake in shares of Centene Co. (NYSE:CNC - Free Report) by 19.1% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 4,666,916 shares of the company's stock after selling 1,101,618 shares during the quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC owned approximately 0.92% of Centene worth $282,722,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Capital Advisors Ltd. LLC lifted its holdings in Centene by 75.3% during the 4th quarter. Capital Advisors Ltd. LLC now owns 412 shares of the company's stock worth $25,000 after buying an additional 177 shares during the period. Hurley Capital LLC acquired a new stake in shares of Centene during the fourth quarter worth $26,000. Rialto Wealth Management LLC acquired a new stake in shares of Centene during the fourth quarter worth $30,000. Studio Investment Management LLC acquired a new stake in shares of Centene during the fourth quarter worth $32,000. Finally, OFI Invest Asset Management acquired a new stake in shares of Centene during the fourth quarter worth $33,000. 93.63% of the stock is owned by institutional investors and hedge funds.
Wall Street Analysts Forecast Growth
CNC has been the subject of several recent analyst reports. Robert W. Baird decreased their price objective on shares of Centene from $71.00 to $69.00 and set a "neutral" rating for the company in a research report on Tuesday, April 15th. Wall Street Zen cut shares of Centene from a "strong-buy" rating to a "buy" rating in a research report on Monday, April 28th. Barclays dropped their price target on Centene from $93.00 to $84.00 and set an "overweight" rating on the stock in a research note on Monday, April 28th. Wells Fargo & Company dropped their price target on Centene from $76.00 to $72.00 and set an "overweight" rating on the stock in a research note on Friday, February 14th. Finally, Guggenheim reissued a "neutral" rating on shares of Centene in a research note on Tuesday, April 29th. Seven equities research analysts have rated the stock with a hold rating and ten have issued a buy rating to the company. According to data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average price target of $79.77.
Get Our Latest Stock Report on Centene
Centene Stock Down 2.8%
CNC traded down $1.65 during trading on Friday, hitting $56.43. 5,205,572 shares of the company's stock were exchanged, compared to its average volume of 4,894,312. The company has a quick ratio of 1.10, a current ratio of 1.11 and a debt-to-equity ratio of 0.70. The business's 50 day moving average is $60.76 and its two-hundred day moving average is $60.33. Centene Co. has a fifty-two week low of $55.03 and a fifty-two week high of $80.59. The stock has a market cap of $28.08 billion, a P/E ratio of 9.04, a PEG ratio of 0.80 and a beta of 0.48.
Centene (NYSE:CNC - Get Free Report) last released its quarterly earnings data on Friday, April 25th. The company reported $2.90 earnings per share for the quarter, topping the consensus estimate of $2.52 by $0.38. Centene had a net margin of 2.03% and a return on equity of 13.85%. The firm had revenue of $46.62 billion for the quarter, compared to the consensus estimate of $43.16 billion. During the same quarter in the prior year, the company posted $2.26 earnings per share. The business's revenue was up 15.4% on a year-over-year basis. As a group, equities analysts expect that Centene Co. will post 6.86 earnings per share for the current fiscal year.
About Centene
(
Free Report)
Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children's health insurance program, foster care, medicare-medicaid plans, long-term services and support.
Featured Stories

Before you consider Centene, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Centene wasn't on the list.
While Centene currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.